keyword
https://read.qxmd.com/read/38711894/lobular-capillary-hemangioma-post-chemotherapy-for-t-cell-leukemia-treated-with-an-antibiotic-a-case-report
#1
Mohammed Al-Haddab, Tharaa N Almughera, Abdulaziz Alsalhi, Nuha Alfurayh
BACKGROUND: Lobular capillary hemangioma, also known as pyogenic granuloma (PG), is a relatively common benign rapidly growing friable vascular tumor of the skin and mucus membranes. Although the exact pathogenesis of PG is unknown, many theories discussed the potential of an angiogenic stimulus and an imbalance of inducers and inhibitors triggering the hyperplastic and neovascular response. The most frequently used modality for treatment of PG is surgical treatment. The proposed case represents an unexpected evolution to a possible therapeutic measure...
2024: AME Case Reports
https://read.qxmd.com/read/38682355/novel-variant-in-nudix-hydrolase-15-gene-influences-6-mercaptopurine-toxicity-in-childhood-acute-lymphoblastic-leukemia-patients
#2
JOURNAL ARTICLE
Zarina Sabirova, Shazia Mahnoor, Dina Lasfar, Vincent Gagné, Yves Théorêt, Jean Marie Leclerc, Caroline Laverdière, Daniel Sinnett, Thai-Hoa Tran, Maja Krajinovic
Acute lymphoblastic leukemia (ALL) is the most frequent pediatric cancer. 6-Mercaptopurine (6-MP) is a key component of ALL treatment. Its use, however, is also associated with adverse drug reactions, particularly myelosuppression. Thiopurine S-methyltransferase (TPMT) and, more recently, Nudix hydrolase 15 (NUDT15) deficiency, due to no-function variants in their respective genes, are well known for their role in the development of this toxicity. Two novel genetic variants, rs12199316 in TPMT and rs73189762 in the NUDT15 gene, were recently identified by targeted sequencing...
April 15, 2024: Pharmacogenetics and Genomics
https://read.qxmd.com/read/38654336/application-of-a-novel-deep-eutectic-solvent-modified-carbon-nanotube-for-pipette-tip-micro-solid-phase-extraction-of-6-mercaptopurine
#3
JOURNAL ARTICLE
Leila Raisi, Sayyed Hossein Hashemi, Ahmad Jamali Keikha, Massoud Kaykhaii
BACKGROUND: 6-mercaptopurine (6-MP) is a chemotherapy drug mainly used to treat leukemia. It is a persistent organic pollutant and can remain in the environment for a long period of time. The presence of 6-MP in the environment poses a number of hazards and needs to be assessed to monitor its potential risk to human health and the environment. However, due to its trace amount in complicated matrices, a clean-up and preconcentration step before its determination is compulsory. RESULTS: As a highly efficient adsorbent for the extrication of 6-mercaptopurine (6-MP), a novel carbon nanotube doped with camphor: decanoic acid deep eutectic solvent was synthesized and applied as a packing material for the pipette-tip micro solid phase extraction sorbent of 6-MP from tap, wastewater and seawater samples before its spectrophotometric determination...
April 23, 2024: BMC chemistry
https://read.qxmd.com/read/38604467/injectable-composite-hydrogels-embedded-with-gallium-based-liquid-metal-particles-for-solid-breast-cancer-treatment-via-chemo-photothermal-combination
#4
JOURNAL ARTICLE
Wonjeong Lee, Min Joo Shin, Sungjun Kim, Chae Eun Lee, Jonghoon Choi, Hyung-Jun Koo, Min-Jae Choi, Jae Ho Kim, Kyobum Kim
Photothermal therapy (PTT) holds great promise as a cancer treatment modality by generating localized heat at the tumor site. Among various photothermal agents, gallium-based liquid metal (LM) has been widely used as a new photothermal-inducible metallic compound due to its structural transformability. To overcome limitations of random aggregation and dissipation of administrated LM particles into a human body, we developed LM-containing injectable composite hydrogel platforms capable of achieving spatiotemporal PTT and chemotherapy...
April 9, 2024: Acta Biomaterialia
https://read.qxmd.com/read/38604042/ruzn-nps-with-electroactivity-and-oxidase-like-property-for-dual-mode-anti-cancer-drug-monitoring
#5
JOURNAL ARTICLE
Zhao Jin, Fang Peng, Qiaodan Du, Dan Liang, Yuan Zhao
6-mercaptopurine (6-MP) as the effective anti-cancer drug was used for the treatment of Crohn's disease and acute lymphoblastic leukaemia, but the response to maintenance therapy was variable with individual differences. In order to control the dosage and decrease the side effects of 6-MP, a sensitive and stable assay was urgently needed for 6-MP monitoring. Herein, RuZn NPs with electrochemical oxidation property and oxidase-like activity was proposed for dual-mode 6-MP monitoring. Burr-like RuZn NPs were prepared and explored to not only exhibit an electrochemical oxidation signal at 0...
April 8, 2024: Talanta
https://read.qxmd.com/read/38589597/real-world-nudt15-genotyping-and-thiopurine-treatment-optimization-in-inflammatory-bowel-disease-a-multicenter-study
#6
JOURNAL ARTICLE
Motoki Makuuchi, Yoichi Kakuta, Junji Umeno, Toshimitsu Fujii, Tetsuya Takagawa, Takashi Ibuka, Miki Miura, Yu Sasaki, Sakuma Takahashi, Hiroshi Nakase, Hiroki Kiyohara, Keiichi Tominaga, Yosuke Shimodaira, Sakiko Hiraoka, Nobuhiro Ueno, Shunichi Yanai, Takeo Yoshihara, Kazuki Kakimoto, Katsuyoshi Matsuoka, Ryohei Hayashi, Sohachi Nanjo, Itaru Iwama, Yoh Ishiguro, Hirofumi Chiba, Katsuya Endo, Takashi Kagaya, Tomohiro Fukuda, Yasuhisa Sakata, Takahiro Kudo, Tomohisa Takagi, Kenichi Takahashi, Makoto Naganuma, Masaru Shinozaki, Noriyuki Ogata, Hiroki Tanaka, Kazuyuki Narimatsu, Haruka Miyazaki, Takashi Ishige, Motoyuki Onodera, Yu Hashimoto, Hiroshi Nagai, Yusuke Shimoyama, Takeo Naito, Rintaro Moroi, Hisashi Shiga, Yoshitaka Kinouchi, Akira Andoh, Tadakazu Hisamatsu, Atsushi Masamune
BACKGROUND: This study evaluated the effectiveness of NUDT15 codon 139 genotyping in optimizing thiopurine treatment for inflammatory bowel disease (IBD) in Japan, using real-world data, and aimed to establish genotype-based treatment strategies. METHODS: A retrospective analysis of 4628 IBD patients who underwent NUDT15 codon 139 genotyping was conducted. This study assessed the purpose of the genotyping test and subsequent prescriptions following the obtained results...
April 8, 2024: Journal of Gastroenterology
https://read.qxmd.com/read/38485947/histidine-re-sensitizes-pediatric-acute-lymphoblastic-leukemia-to-6-mercaptopurine-through-tetrahydrofolate-consumption-and-sirt5-mediated-desuccinylation
#7
JOURNAL ARTICLE
Na Dong, Hui-Xian Ma, Xue-Qin Liu, Dong Li, Ling-Hong Liu, Qing Shi, Xiu-Li Ju
Despite progressive improvements in the survival rate of pediatric B-cell lineage acute lymphoblastic leukemia (B-ALL), chemoresistance-induced disease progression and recurrence still occur with poor prognosis, thus highlighting the urgent need to eradicate drug resistance in B-ALL. The 6-mercaptopurine (6-MP) is the backbone of ALL combination chemotherapy, and resistance to it is crucially related to relapse. The present study couples chemoresistance in pediatric B-ALL with histidine metabolism deficiency...
March 14, 2024: Cell Death & Disease
https://read.qxmd.com/read/38480674/distal-toxic-acral-erythema-and-mucositis-secondary-to-6-mercaptopurine-in-a-thiopurine-methyltransferase-super-shunter
#8
Sydney Smith, Daniel Grove
Toxic erythema of chemotherapy is a broad but useful diagnosis used to summate the non-infectious, non-allergic, and reproducible reaction of certain chemotherapeutics. Due to overlapping chemotherapy side effects and often multiple drug exposures, identification of a singular culprit drug is challenging for dermatologists. Herein, we report a patient with 6-mercaptopurine (6-MP) toxic erythema confirmed via toxic metabolite markers secondary to increased levels of thiopurine methyltransferase activity, or so called "super shunting...
March 13, 2024: Pediatric Dermatology
https://read.qxmd.com/read/38470810/correction-jamal-et-al-preparation-of-6-mercaptopurine-loaded-liposomal-formulation-for-enhanced-cytotoxic-response-in-cancer-cells-nanomaterials-2022-12-4029
#9
Alam Jamal, Amer H Asseri, Ehab M M Ali, Afnan H El-Gowily, Mohamed Imran Khan, Salman Hosawi, Reem Alsolami, Tarek A Ahmed
In the original publication [...].
February 28, 2024: Nanomaterials
https://read.qxmd.com/read/38464784/n-s-br-co-doped-carbon-dots-one-step-synthesis-and-fluorescent-detection-of-6-mercaptopurine-in-tablet
#10
JOURNAL ARTICLE
Qi Wang, Ying Cheng, Lifeng Ding, Shengling Li, Jie Zhang, Yulan Niu, Ziye Jing
Scheme of synthesis of N, S, Br-CDs and fluorescent detection of 6-MP.Image 1.
February 2024: Journal of Pharmaceutical Analysis
https://read.qxmd.com/read/38447438/a-novel-turn-on-fluorescence-sensor-based-on-the-nd-iii-complex-for-the-ultrasensitive-detection-of-6-mercaptopurine
#11
JOURNAL ARTICLE
Rajpal, Subhajit Jana, Ravi Prakash Ojha, Rajiv Prakash
6-mercaptopurine (6MP) is a chemotherapeuticdrug widely used for treating inflammatory bowel diseases and several cancers. Nevertheless, determining and monitoring its concentration in the human body is highly important because over or under-doses of 6MP can lead to critical health issues. In this paper, we have developed a turn-on fluorescent probe for the determination of the anticancer drug 6-mercaptopurine (6-MP) based on coordination complex [Nd (Anth)3 (H2 O)3 ]. [Nd (Anth)3 (H2 O)3 ] has been synthesized through a simple precipitation process taking the stoichiometric ratio of Nd (III) nitrate hexahydrate and 2-aminobenzoic acid (2-ABA), commonly known as anthranilic acid (Anth)...
February 20, 2024: Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy
https://read.qxmd.com/read/38444060/efficacy-of-optimised-thiopurine-therapy-in-patients-with-moderate-to-severe-ulcerative-colitis-retrospective-long-term-follow-up-from-two-randomised-trials
#12
JOURNAL ARTICLE
Anette Mertz Nielsen, Klaus Theede, Lise Lotte Gluud, Marianne Kiszka-Kanowitz
OBJECTIVE: The long-term outcome of thiopurine therapy in patients with ulcerative colitis (UC) enrolled in prospective trials have not been evaluated. We aimed to assess the effects of optimised thiopurine maintenance therapy for UC. METHODS: Long-term data were obtained from patients from our center enrolled in two randomised, prospective, open-label, controlled studies comprising 66 thiopurine-naïve moderate-to-severe patients with UC consisting of a low dose azathioprine (AZA)/allopurinol combination or AZA monotherapy...
March 5, 2024: Scandinavian Journal of Gastroenterology
https://read.qxmd.com/read/38433609/zinc-doped-hydroxyapatite-as-a-ph-responsive-drug-delivery-system-for-anticancer-drug-6-mercaptopurine
#13
JOURNAL ARTICLE
Marcel Jakubowski, Łukasz Majchrzycki, Aleksej Zarkov, Adam Voelkel, Mariusz Sandomierski
6-Mercaptopurine (6MP) is commonly used in the treatment of acute lymphoblastic leukemia as an important agent in maintenance therapy. Despite its therapeutic benefits, 6MP has some limitations during therapy. Taking into account the disadvantages during 6MP therapy, there is a great need to create an appropriate delivery system for this drug. 6MP contains in its structure nitrogen and sulfur atoms capable of forming coordination compounds with metal ions, for example zinc. Therefore, in this work, we prepared biocompatible hydroxyapatite (HAp) doped with zinc ions, and used it as a carrier for 6MP...
March 2024: Journal of Biomedical Materials Research. Part B, Applied Biomaterials
https://read.qxmd.com/read/38417937/mercaptopurine-induced-sweet-s-syndrome
#14
JOURNAL ARTICLE
Natalie Commins, Deloshaan Subhaharan, Andrew Dettrick, Desmond Patrick
Sweet's syndrome is an acute febrile neutrophilic dermatosis. Drug-induced Sweet's syndrome typically occurs soon after drug administration, with rapid resolution of symptoms with cessation of the offending agent. We report a man in his early 40s who presented with fever and widespread erythematous rash on a background of recently diagnosed mild stricturing ileal Crohn's disease. He was commenced on 6-mercaptopurine 12 days before presentation. Skin biopsy demonstrated diffuse infiltration of neutrophils in the upper dermis, dermal oedema, eosinophils and fibrin deposition...
February 27, 2024: BMJ Case Reports
https://read.qxmd.com/read/38411659/hypoglycemia-associated-with-peg-asparaginase-and-6-mp-therapy-during-treatment-of-acute-lymphoblastic-leukemia-in-pediatric-patients-a-case-series
#15
JOURNAL ARTICLE
Mary R Jiang, Alexandra Ahmet, Sarah Lawrence, Mylene Bassal, Matthew Speckert, Michael T Geraghty, Scott Somerville
BACKGROUND: Asparaginases are a mainstay treatment for pediatric acute lymphoblastic leukemia (ALL). Recent reports identified hypoglycemia associated with asparaginases. Other reports describe hypoglycemia associated with 6-mercaptopurine (6-MP), another fundamental ALL therapy. Little is known about the risk of hypoglycemia associated with ALL therapy, an adverse event that puts children at risk of decreased level of consciousness, seizures, and possibly negative neurocognitive sequelae...
March 1, 2024: Journal of Pediatric Hematology/oncology
https://read.qxmd.com/read/38399389/antiviral-potential-of-azathioprine-and-its-derivative-6-mercaptopurine-a-narrative-literature-review
#16
REVIEW
Carolina Rios-Usuga, Marlen Martinez-Gutierrez, Julian Ruiz-Saenz
The use of azathioprine (AZA) in human medicine dates back to research conducted in 1975 that led to the development of several drugs, including 6-mercaptopurine. In 1958, it was shown that 6-mercaptopurine decreased the production of antibodies against earlier administered antigens, raising the hypothesis of an immunomodulatory effect. AZA is a prodrug that belongs to the thiopurine group of drugs that behave as purine analogs. After absorption, it is converted into 6-mercaptopurine. Subsequently, it can be degraded through various enzymatic pathways into inactive compounds and biologically active compounds related to the mechanism of action, which has been the subject of study to evaluate a possible antiviral effect...
January 30, 2024: Pharmaceuticals
https://read.qxmd.com/read/38397272/profound-hypoglycemia-and-high-anion-gap-metabolic-acidosis-in-a-pediatric-leukemic-patient-receiving-6-mercaptopurine
#17
Molly O'Shea, Alexis Kuhn, Ana L Creo, Mira Kohorst, Asmaa Ferdjallah
A 13-year-old male undergoing maintenance chemotherapy with methotrexate and 6-mercaptopurine (6MP), for very high-risk B-cell acute lymphoblastic leukemia (ALL), presented with vomiting due to severe hypoglycemia with metabolic acidosis. While his laboratory values were concerning for a critically ill child, the patient was relatively well appearing. Hypoglycemia is a rare but serious side effect of 6MP with an unexpectedly variable presentation; therefore, a high index of suspicion is needed for its prompt detection and treatment...
January 26, 2024: Children
https://read.qxmd.com/read/38384282/the-drug-survival-of-low-dose-thioguanine-in-patients-with-inflammatory-bowel-disease-a-retrospective-observational-study
#18
JOURNAL ARTICLE
Helena Gensmyr-Singer, Mårten Werner, Pontus Karling
BACKGROUND: Thiopurines are commonly used to treat inflammatory bowel disease but withdrawal due to side effects are common. Thioguanine has been suggested to be better tolerated than conventional thiopurines. OBJECTIVES: We studied drug-survival of low dose of thioguanine in real-life clinical practice in comparison to conventional thiopurines. DESIGN: Retrospective observational study. METHODS: All patients born 1956 and later, and who at least once started thiopurine treatment between 2006 and 2022 were included...
2024: Therapeutic Advances in Gastroenterology
https://read.qxmd.com/read/38356449/effects-of-allopurinol-on-6-mercaptopurine-metabolism-in-unselected-patients-with-pediatric-acute-lymphoblastic-leukemia-a-prospective-phase-ii-study
#19
JOURNAL ARTICLE
Jonatan Källström, Riita Niinimäki, Johan Fredlund, Hartmut Vogt, Laura Korhonen, Anders Castor, Josefine Palle, Arja Harila, Magnus Borssén, Jonas Abrahamsson, Torben Ek
Allopurinol can be used in maintenance therapy (MT) for pediatric acute lymphoblastic leukemia (ALL) to mitigate hepatic toxicity in patients with skewed 6- mercaptopurine metabolism. Allopurinol increases the erythrocyte levels of thioguanine nucleotides (e-TGN), which is the proposed main mediator of the antileukemic effect and decreases methyl mercaptopurine (e-MeMP) levels, associated with hepatotoxicity. We investigated the effects of allopurinol in thiopurine methyltransferase (TPMT) wild-type patients without previous clinical signs of skewed 6MP metabolism...
February 15, 2024: Haematologica
https://read.qxmd.com/read/38330760/a-stable-and-sensitive-2d-sers-sensor-for-bioanalytical-applications
#20
JOURNAL ARTICLE
Marianna Pannico, Pellegrino Musto
In this study, we describe a 2D-SERS sensor obtained by deposition of spherical gold nanoparticles (AuNPs) onto a suitably functionalized metal surface. Morphological analysis of the SERS surface by SEM and AFM demonstrated a uniform and stable distribution of the active nanoparticles. Following p-mercaptoaniline (pMA) functionalization, the sensor was characterized by co-localized Raman measurements, demonstrating a significant enhancement in Raman signals with homogeneous SERS activity across the entire sampled area...
February 1, 2024: Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy
keyword
keyword
20140
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.